Alkermes (ALKS) Gains from Sales and Divestitures (2016 - 2025)
Alkermes (ALKS) has disclosed Gains from Sales and Divestitures for 14 consecutive years, with $2.0 million as the latest value for Q4 2025.
- On a quarterly basis, Gains from Sales and Divestitures rose 281.26% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 281.26% increase, with the full-year FY2025 number at $2.0 million, up 281.26% from a year prior.
- Gains from Sales and Divestitures was $2.0 million for Q4 2025 at Alkermes, up from $536243.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $2.6 million in Q4 2023 to a low of $177946.0 in Q4 2021.
- A 5-year average of $1.5 million and a median of $2.0 million in 2025 define the central range for Gains from Sales and Divestitures.
- Peak YoY movement for Gains from Sales and Divestitures: tumbled 83.78% in 2021, then surged 1053.09% in 2022.
- Alkermes' Gains from Sales and Divestitures stood at $177946.0 in 2021, then soared by 1053.09% to $2.1 million in 2022, then increased by 26.39% to $2.6 million in 2023, then tumbled by 79.32% to $536243.0 in 2024, then skyrocketed by 281.26% to $2.0 million in 2025.
- Per Business Quant, the three most recent readings for ALKS's Gains from Sales and Divestitures are $2.0 million (Q4 2025), $536243.0 (Q4 2024), and $2.6 million (Q4 2023).